Identification of the gene controlling murine retrovirus in YBR mice
Identification of the gene controlling murine retrovirus in YBR mice
批准号:
10724724
负责人:
Tatyana V Golovkina
金额:
$24.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2025-07-31
关键词:
AllelesAntibodiesAutomobile DrivingCandidate Disease GeneChromosome 18Computer AnalysisCytotoxic T-LymphocytesDiseaseDominant GenesExhibitsGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic studyGoalsHIVHealthHumanImmune responseInbred MouseIndividualInfectionInheritedKnowledgeLymphocyteLymphoid CellMammary NeoplasmsMammary TumorigenesisMammary glandMapsMediatingMilkModelingMouse Mammary Tumor VirusMouse StrainsMucous MembraneMusNamesNatural Killer CellsPopulationPredispositionResistanceRetroviridaeStudy modelsSusceptibility GeneT-Lymphocyte and Natural Killer CellTherapeuticTumor Virus InfectionsVaccinesVariantViralVirusVirus DiseasesVirus ReplicationYBR Mouseattenuationcandidate identificationcytotoxic CD8 T cellsexperimental studygenetic makeuphuman pathogenmicrobialneutralizing antibodypathogenpathogenic viruspupresistance generesistance mechanismresponsesucklingtransmission processtumortumorigenesis
中文摘要
摘要
对病毒感染的不同反应受宿主基因组成的影响。因此,在本发明中,
人类对病毒感染的敏感性差异很大,有些人能抵抗强病毒感染,
病原体,如逆转录病毒、人类免疫缺陷病毒(HIV)。遗传抗性的研究
人类中的逆转录病毒非常复杂,因此很难分离出强大的抗病毒药物。
在开发治疗剂和疫苗时可以利用的效应器机制。然而,在这方面,
近交系小鼠对病毒感染的易感性的变化使得小鼠成为用于
绘制哺乳动物对逆转录病毒易感性和抗性的机制和基因。外源
小鼠乳腺肿瘤病毒(MMTV)代表了一种被充分研究的粘膜传播逆转录病毒模型。的
病毒通过乳鼠肠道中的乳汁获得,并通过
淋巴细胞,在几个周期的再感染/再整合后诱导乳腺肿瘤。
对外源性MMTV感染和随后的乳腺肿瘤发生的易感性在以下人群中差异很大:
不同的小鼠品系,从绝对抗性到高敏感性。MMTV耐药小鼠
YBR/Ei(YBR)菌株被病毒感染,但不发生乳腺肿瘤,产生降低的病毒滴度,
并在连续世代中有效地消除病原体。在我们的初步研究中,我们发现
YBR小鼠中病毒控制的独特机制与抗病毒抗体(Abs)、病毒特异性CD 8 +
细胞毒性T淋巴细胞、自然杀伤(NK)细胞和NK T细胞,但依赖于Thy 1+淋巴细胞。
此外,病毒的限制作用是由一个单一的、显性的位点控制的,我们称之为病毒减毒
滴度(AVT),并已定位于染色体18。利用遗传学研究和计算分析,我们将
确定负责这种显著效应机制的基因。
英文摘要
Abstract
Differential responses to viral infections are influenced by the genetic makeup of the host. As a result,
sensitivity of humans to viral infections varies considerably, with some individuals withstanding strong viral
pathogens, such as the retrovirus, human immunodeficiency virus (HIV). Studies of inherited resistance to
retroviruses in human populations are enormously complicated, making it difficult to dissect strong antiviral
effector mechanisms that can be taken advantage of when developing therapeutics and vaccines. However,
the variations in the susceptibility of inbred mice to viral infections make the mouse an excellent model for
mapping mechanisms and genes driving mammalian susceptibility and resistance to retroviruses. Exogenous
mouse mammary tumor virus (MMTV) represents a well-studied model of mucosally transmitted retrovirus. The
virus is acquired through the milk in the gut of suckling pups and is passed to the mammary glands by
lymphocytes, where it induces mammary gland tumors after several cycles of re-infection/re-integration.
Susceptibility to exogenous MMTV infection and subsequent mammary tumorigenesis differs drastically among
different mouse strains, ranging from absolute resistance to high susceptibility. Mice from the MMTV-resistant
YBR/Ei (YBR) strain become virus-infected, but do not develop mammary tumors, produce reduced virus titers,
and efficiently eliminate the pathogen in successive generations. In our preliminary studies we found that the
unique mechanism of virus control in YBR mice is unrelated to anti-virus antibodies (Abs), virus-specific CD8+
cytotoxic T lymphocytes, natural killer (NK) cells, and NK T cells, but depends on Thy1+ lymphoid cells.
Moreover, the virus restriction is controlled by a single, dominant locus, which we named attenuation of virus
titers (avt) and have mapped to chromosome 18. Using genetic studies and computational analyses, we will
identify the gene responsible for this remarkable effector mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A neonatal mouse model to study retrovirus-specific humoral responses
-
批准号:9789817
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2018
-
负责人:Tatyana V Golovkina
-
依托单位:
A neonatal mouse model to study retrovirus-specific humoral responses
-
批准号:10459482
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2018
-
负责人:Tatyana V Golovkina
-
依托单位:
A neonatal mouse model to study retrovirus-specific humoral responses
-
批准号:10241945
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2018
-
负责人:Tatyana V Golovkina
-
依托单位:
A neonatal mouse model to study retrovirus-specific humoral responses
-
批准号:9988632
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2018
-
负责人:Tatyana V Golovkina
-
依托单位:
Genetic Basis for Sensitivity of Neonates to Retroviruses
-
批准号:9195081
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2015
-
负责人:Tatyana V Golovkina
-
依托单位:
New retroviral restriction factor
-
批准号:9029814
-
项目类别:
-
资助金额:$65.98万
-
财政年份:2015
-
负责人:Tatyana V Golovkina
-
依托单位:
New retroviral restriction factor
-
批准号:10441970
-
项目类别:
-
资助金额:$77.62万
-
财政年份:2015
-
负责人:Tatyana V Golovkina
-
依托单位:
Leukemia-promoting effects of microbiota
-
批准号:9110906
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2015
-
负责人:Tatyana V Golovkina
-
依托单位:
Retroviral Evasion of Immune Response
-
批准号:8372384
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2011
-
负责人:Tatyana V Golovkina
-
依托单位:
Retroviral Evasion of Immune Response
-
批准号:8237357
-
项目类别:
-
资助金额:$43.21万
-
财政年份:2011
-
负责人:Tatyana V Golovkina
-
依托单位:
Retroviral evasion of immune response
-
批准号:8083300
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2010
-
负责人:Tatyana V Golovkina
-
依托单位:
Cloning of the vic1 gene, a novel retrovirus restriction factor
-
批准号:7659667
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2008
-
负责人:Tatyana V Golovkina
-
依托单位:
Cloning of the vic1 gene, a novel retrovirus restriction factor
-
批准号:8257960
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2008
-
负责人:Tatyana V Golovkina
-
依托单位:
Cloning of the vic1 gene, a novel retrovirus restriction factor
-
批准号:8077389
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2008
-
负责人:Tatyana V Golovkina
-
依托单位:
Novel pathways in Retroviral Tumorigenesis
-
批准号:7264672
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2006
-
负责人:Tatyana V Golovkina
-
依托单位:
Novel pathways in Retroviral Tumorigenesis
-
批准号:7619022
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2006
-
负责人:Tatyana V Golovkina
-
依托单位:
Novel pathways in Retroviral Tumorigenesis
-
批准号:7150677
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2006
-
负责人:Tatyana V Golovkina
-
依托单位:
Novel pathways in Retroviral Tumorigenesis
-
批准号:7436149
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2006
-
负责人:Tatyana V Golovkina
-
依托单位:
Subversion of Innate Immune Response by Retroviruses
-
批准号:6876596
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2003
-
负责人:Tatyana V Golovkina
-
依托单位:
Subversion of Innate Immune Response by Retroviruses
-
批准号:6734189
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2003
-
负责人:Tatyana V Golovkina
-
依托单位:
海外基金